GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

This study provides valuable guidance for doctors and patients when choosing diabetes medications. It confirms that ...

Metformin is the first-line treatment for the majority of people with type 2 diabetes. Over time, you might need to add other oral meds, insulin, or other injectable drugs, like a GLP-1 receptor ...

There has been recent interest in whether glucagon-like peptide-1 receptor agonists (GLP-1RAs) affect depression risk. One recent study found that GLP-1RAs may help lower the risk for depression ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Researchers found that apple peels from local and commercial varieties are rich in phenolic compounds with antioxidant and ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

New research suggests that medications originally developed for diabetes and obesity could have potential benefits for mental ...

Use of GLP-1 receptor agonists for obesity was associated with a reduced risk of primary open-angle glaucoma (POAG) and ...